Cargando…
Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial
INTRODUCTION: Rapid onset and sustained efficacy are important for acute migraine treatment. Global phase 3 trials have demonstrated the early onset and sustained efficacy of the 5-HT(1F) receptor agonist lasmiditan. In this prespecified analysis of the MONONOFU study, we assessed the onset and sust...
Autores principales: | Matsumori, Yasuhiko, Komori, Mika, Tanji, Yuka, Ozeki, Akichika, Sakai, Fumihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588099/ https://www.ncbi.nlm.nih.gov/pubmed/36136232 http://dx.doi.org/10.1007/s40120-022-00403-2 |
Ejemplares similares
-
Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial
por: Takeshima, Takao, et al.
Publicado: (2022) -
Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study
por: Kitamura, Shigekazu, et al.
Publicado: (2023) -
Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients
por: Sakai, Fumihiko, et al.
Publicado: (2021) -
Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial
por: Shibata, Mamoru, et al.
Publicado: (2023) -
Lasmiditan for the acute treatment of migraine: Subgroup analyses by
prior response to triptans
por: Knievel, Kerry, et al.
Publicado: (2019)